Elisabeth Jameson

988 total citations
22 papers, 402 citations indexed

About

Elisabeth Jameson is a scholar working on Molecular Biology, Clinical Biochemistry and Physiology. According to data from OpenAlex, Elisabeth Jameson has authored 22 papers receiving a total of 402 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 10 papers in Clinical Biochemistry and 9 papers in Physiology. Recurrent topics in Elisabeth Jameson's work include Metabolism and Genetic Disorders (10 papers), Lysosomal Storage Disorders Research (8 papers) and Mitochondrial Function and Pathology (5 papers). Elisabeth Jameson is often cited by papers focused on Metabolism and Genetic Disorders (10 papers), Lysosomal Storage Disorders Research (8 papers) and Mitochondrial Function and Pathology (5 papers). Elisabeth Jameson collaborates with scholars based in United Kingdom, United States and Germany. Elisabeth Jameson's co-authors include Simon Jones, Tracey Remmington, John H. Walter, Jane Ashworth, Pauline Hensman, Saikat Santra, Bernd Schwahn, Jean Mercer, Abdel Ali Belaidi and Günter Schwarz and has published in prestigious journals such as The Lancet, Cochrane Database of Systematic Reviews and Human Molecular Genetics.

In The Last Decade

Elisabeth Jameson

22 papers receiving 394 citations

Peers

Elisabeth Jameson

PHYSI

RHEUM

EPIDE

Drago Bratkovic Australia

David F. Kronn United States

Helen Mundy United Kingdom

Andrea M. Atherton United States

Hélène Ogier France

Xinying Hong United States

Go Tajima Japan

Maja Djordjevic Serbia

Ebru Canda Türkiye

Sita Arjune Germany

Drago Bratkovic Australia

Elisabeth Jameson

157 ×0.8

PHYSI

200 ×1.7

131 ×1.3

70 ×0.8

RHEUM

46 ×0.5

EPIDE

Citations per year, relative to Elisabeth Jameson Elisabeth Jameson (= 1×) peers Drago Bratkovic

Countries citing papers authored by Elisabeth Jameson

Since Specialization

Citations

This map shows the geographic impact of Elisabeth Jameson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Elisabeth Jameson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Elisabeth Jameson more than expected).

Fields of papers citing papers by Elisabeth Jameson

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Elisabeth Jameson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Elisabeth Jameson. The network helps show where Elisabeth Jameson may publish in the future.

Co-authorship network of co-authors of Elisabeth Jameson

This figure shows the co-authorship network connecting the top 25 collaborators of Elisabeth Jameson. A scholar is included among the top collaborators of Elisabeth Jameson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Elisabeth Jameson. Elisabeth Jameson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Jameson, Elisabeth & Tracey Remmington. (2020). Dietary interventions for phenylketonuria. Cochrane Database of Systematic Reviews. 2021(4). CD001304–CD001304. 13 indexed citations

Jameson, Elisabeth, Simon Jones, & Tracey Remmington. (2019). Enzyme replacement therapy with laronidase (Aldurazyme®) for treating mucopolysaccharidosis type I. Cochrane Database of Systematic Reviews. 2021(4). 29 indexed citations

Broomfield, Alexander, James Davison, Joseph Roberts, et al.. (2019). Ten years of enzyme replacement therapy in paediatric onset mucopolysaccharidosis II in England. Molecular Genetics and Metabolism. 129(2). 98–105. 36 indexed citations

Oláhová, Monika, Jack J. Collier, Charlotte L. Alston, et al.. (2019). Molecular genetic investigations identify new clinical phenotypes associated with BCS1L-related mitochondrial disease. Human Molecular Genetics. 28(22). 3766–3776. 17 indexed citations

Jameson, Elisabeth & John H. Walter. (2019). Medium-chain acyl-CoA dehydrogenase deficiency. Paediatrics and Child Health. 29(3). 123–126. 4 indexed citations

Mercer, Jean, et al.. (2016). Outcomes of Long-Term Treatment with Laronidase in Patients with Mucopolysaccharidosis Type I. The Journal of Pediatrics. 178. 219–226.e1. 38 indexed citations

Harmatz, Paul, Eugen Mengel, Tarekegn Geberhiwot, et al.. (2016). Impact of elosulfase alfa in patients with morquio A syndrome who have limited ambulation: An open‐label, phase 2 study. American Journal of Medical Genetics Part A. 173(2). 375–383. 22 indexed citations

Jameson, Elisabeth, Simon Jones, & Tracey Remmington. (2016). Enzyme replacement therapy with laronidase (Aldurazyme^®) for treating mucopolysaccharidosis type I. Cochrane Database of Systematic Reviews. 4. CD009354–CD009354. 49 indexed citations

Jameson, Elisabeth, et al.. (2015). Optic neuropathy in methylmalonic acidemia and propionic acidemia. British Journal of Ophthalmology. 100(1). 98–104. 21 indexed citations

10.

Jameson, Elisabeth & John H. Walter. (2015). Medium-chain acyl-CoA dehydrogenase deficiency. Paediatrics and Child Health. 25(3). 145–148. 5 indexed citations

11.

Schwahn, Bernd, Francjan J. van Spronsen, Abdel Ali Belaidi, et al.. (2015). Efficacy and safety of cyclic pyranopterin monophosphate substitution in severe molybdenum cofactor deficiency type A: a prospective cohort study. The Lancet. 386(10007). 1955–1963. 99 indexed citations

12.

Broomfield, Alexander, et al.. (2014). Reversal of Respiratory Failure in Both Neonatal and Late Onset Isolated Remethylation Disorders. JIMD Reports. 16. 51–56. 8 indexed citations

13.

Jameson, Elisabeth, Simon Jones, & J. E. Wraith. (2013). Enzyme replacement therapy with laronidase (Aldurazyme^®) for treating mucopolysaccharidosis type I. Cochrane Database of Systematic Reviews. CD009354–CD009354. 3 indexed citations

14.

Jameson, Elisabeth & Andrew A. M. Morris. (2011). Nutrition in metabolic disease. Paediatrics and Child Health. 21(9). 401–405. 3 indexed citations

15.

Jameson, Elisabeth & John H. Walter. (2011). Medium-chain acyl-CoA dehydrogenase deficiency – a review. Paediatrics and Child Health. 21(2). 90–93. 1 indexed citations

16.

Jameson, Elisabeth & Andrew A.M. Morris. (2011). Mitochondrial disease – a review. Paediatrics and Child Health. 21(2). 80–83. 4 indexed citations

17.

Jameson, Elisabeth, et al.. (2010). An all-consuming case. Archives of Disease in Childhood Education & Practice. 96(1). 31–36. 1 indexed citations

18.

Jameson, Elisabeth. (2010). Question 3 Ketamine or midazolam: does it matter which?. Archives of Disease in Childhood. 96(1). 106–108. 2 indexed citations

19.

Jameson, Elisabeth & John H. Walter. (2007). Cardiac Arrest Secondary to Long QTC in a Child with Propionic Acidemia. Pediatric Cardiology. 29(5). 969–970. 25 indexed citations

20.

Weimer, H. E., et al.. (1955). Serum Glycoprotein Concentrations Following Immunization in the Rabbit.. Experimental Biology and Medicine. 88(4). 571–574. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact